| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/17/1998 | CA2283184A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 09/17/1998 | CA2282398A1 Inhibitors of impdh enzyme |
| 09/16/1998 | EP0864583A2 Alkali metal 8,9-dehydroestrone sulfate esters |
| 09/16/1998 | EP0864582A2 Hypolipidemic 1,4-benzothiazepine-1,-dioxides |
| 09/16/1998 | EP0864568A1 Agents for treatment of cardiac diseases |
| 09/16/1998 | EP0864561A1 Benzenesulfonylamine derivatives,process for their preparation and pharmaceutical compositions containing them |
| 09/16/1998 | EP0864087A1 Combinatorial dihydrobenzopyran library |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863914A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863896A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 09/16/1998 | EP0863892A1 Lipophilic benzothiophenes |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863876A1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 09/16/1998 | EP0863875A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 09/16/1998 | EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 09/16/1998 | EP0728128B1 Substituted phenyl compounds |
| 09/16/1998 | EP0724637B1 Corticotropin-releasing factor 2 receptors |
| 09/16/1998 | EP0707586B1 Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 09/16/1998 | EP0699442B1 Use of a strain of the fungus fusarium as a producer of substances and a preparation based on said substances with adaptogenic and immunomodulating properties |
| 09/16/1998 | EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 09/16/1998 | EP0644897B1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 09/16/1998 | CN1193276A Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 09/16/1998 | CN1193274A Calcium-ion channel antagonists |
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1193017A Sulfamide-substituted condensed seven-membered ring chemical compound, use as medicine and medicinal preparation containing same |
| 09/16/1998 | CN1193012A Sulfamine-substituted chemical compound, preparing process therefor, and use as medicine and diagnosis agent and medicine containing same |
| 09/15/1998 | US5808097 Proline derivatives |
| 09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
| 09/15/1998 | US5808025 Polypeptide |
| 09/15/1998 | US5808021 Method for controlling O-desulfation of heparin |
| 09/15/1998 | US5807951 Pharmaceutical composition regulating function of a living body |
| 09/15/1998 | US5807896 Antiarrhythmia agents; sodium channel modulators; cardiovascular disorders |
| 09/15/1998 | US5807889 Aminomethylindans, -benzofuranes and -benzothiophenes |
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807878 Tetrasubstituted imidazoles |
| 09/15/1998 | US5807876 Inosine-5'-monophospate dehydrogenase; viral diseases, cancer, vascular diseases; merimepodib |
| 09/15/1998 | US5807875 Obesity therapy |
| 09/15/1998 | US5807864 2-thioxo-tetrahydropyrimidin-4-one derivatives |
| 09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
| 09/15/1998 | US5807859 Antiischemic agents; brain disorders |
| 09/15/1998 | US5807857 Migraine |
| 09/15/1998 | US5807844 Therapy for septic shock, infections, toxicity |
| 09/15/1998 | US5807834 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 09/15/1998 | US5807829 Serine protease inhibitor--tripeptoid analogs |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807819 Using an oligopeptide |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807731 Antitumor |
| 09/15/1998 | CA2001750C Pyrrolidine derivatives |
| 09/15/1998 | CA1340047C 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid, a process for the preparation thereof, the use thereof as pharmaceuticals, and intermediates |
| 09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | WO1998039343A1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039299A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors |
| 09/11/1998 | WO1998039284A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | WO1998039280A1 Phenylpropenone compounds and medicines containing the same |
| 09/11/1998 | WO1998039023A1 Treatment of cardiomyopathy |
| 09/11/1998 | WO1998039012A1 USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 09/11/1998 | WO1998038986A2 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections |
| 09/11/1998 | WO1998038985A2 Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998030707A3 Eukaryotic gene expression cassette and uses thereof |
| 09/11/1998 | WO1998030692A3 Human endosulfine gene |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283418A1 Use of a 7.alpha.-methyl-17.alpha.-ethynyl-estrane derivative for the treatment of atherosclerosis |
| 09/11/1998 | CA2283415A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283257A1 Phenylpropenone compounds and medicines containing the same |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/10/1998 | DE19709125A1 Substituierte Chinoline Substituted quinolines |
| 09/09/1998 | EP0863149A1 Process for introducing an amino group on the 14-position of a steroid nucleus |
| 09/09/1998 | EP0863143A1 Intermediates useful in the production of pyridopyrimidone angiotensin AII antagonists |
| 09/09/1998 | EP0862626A1 Pilosulin 2 |
| 09/09/1998 | EP0862619A1 Pskh-1 ribozymes and uses in disease treatment |
| 09/09/1998 | EP0862564A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0862550A1 Carboxylic acid derivatives, their preparation and their use |
| 09/09/1998 | EP0862453A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 09/09/1998 | EP0862444A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 09/09/1998 | EP0862435A1 Inhibitors of farnesyl-protein transferase |
| 09/09/1998 | EP0862434A1 Infusions of neuroprotectants and perfluorochemicals |
| 09/09/1998 | EP0716649B1 5-arylindole derivatives |
| 09/09/1998 | EP0715627B1 Indole derivatives as thromboxane a2 antagonists |
| 09/09/1998 | EP0596057B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 09/09/1998 | EP0589903B1 Aminoalkyl-substituted 5-mercaptothiazoles, their preparation and their use |
| 09/09/1998 | EP0478732B1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/09/1998 | EP0383759B1 N6 substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1192697A Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192696A Spironolactone and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |